Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Rift Valley fever (RVF), caused by the Rift Valley fever virus (RVFV), is an arbovirus characterized by a usually self-limiting febrile illness but that in some cases can also manifest with thrombosis, vision loss, hemorrhages and/or neurological symptoms.
Biomarker and diagnostic research for Rift valley fever has been reported in the published literature.
4 clinical trials registered, 2 recruiting. Interventions under study include other interventions, biologic therapy, and drug therapy. Pipeline includes 2 PHASE2, 1 PHASE1. Research is sponsored by a mix of industry and academic institutions.
267 publications have been identified in PubMed for Rift valley fever. Research spans Epidemiology / Natural History (36%), Basic Science / Preclinical (28%), and Review / Meta-Analysis (15%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 95 |
Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 1:25 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Rift valley fever
Laboratory research | 76 | 28% |
Research summaries | 40 | 15% |
New treatment approaches | 23 | 9% |
Testing and diagnosis research | 18 | 7% |
Other research | 6 | 2% |
Clinical study results | 5 | 2% |
Patient case studies | 4 | 1% |
Pei X (2026). [PMID: 41930445](https://pubmed.ncbi.nlm.nih.gov/41930445/). *Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi*. [Basic Science / Preclinical]
Ali MA (2026). [PMID: 41231874](https://pubmed.ncbi.nlm.nih.gov/41231874/). *Infect Dis (Lond)*. [Epidemiology / Natural History]
Unknown (2026). [PMID: 42044347](https://pubmed.ncbi.nlm.nih.gov/42044347/). *Proc Natl Acad Sci U S A*. [Other]
Gwon YD (2026). [PMID: 42023155](https://pubmed.ncbi.nlm.nih.gov/42023155/). *iScience*. [Basic Science / Preclinical]
Mueller Brown K (2026). [PMID: 42138140](https://pubmed.ncbi.nlm.nih.gov/42138140/). *J Infect Dis*. [Basic Science / Preclinical]
Nkundwanayo C (2026). [PMID: 41961907](https://pubmed.ncbi.nlm.nih.gov/41961907/). *PLoS Negl Trop Dis*. [Basic Science / Preclinical]
Lepore L (2026). [PMID: 41805781](https://pubmed.ncbi.nlm.nih.gov/41805781/). *PLoS Negl Trop Dis*. [Epidemiology / Natural History]
Nyakarahuka L (2026). [PMID: 41754476](https://pubmed.ncbi.nlm.nih.gov/41754476/). *Pathogens*. [Epidemiology / Natural History]
Connors KA (2026). [PMID: 41568981](https://pubmed.ncbi.nlm.nih.gov/41568981/). *J Virol*. [Basic Science / Preclinical]
Fatma F (2026). [PMID: 42264132](https://pubmed.ncbi.nlm.nih.gov/42264132/). *J Mol Biol*. [Basic Science / Preclinical]
AI-curated news mentioning Rift valley fever
Updated Mar 25, 2026
Recent research highlights Rift Valley fever as an emerging zoonotic threat, impacting both global health and agriculture. The findings underscore the need for increased surveillance and response strategies to mitigate its effects.
A report highlights regional increases in the incidence of Valley fever in Arizona from 2005 to 2022, indicating a growing public health concern. This trend may prompt further advocacy and awareness efforts among patient organizations.